Vabysmo 6 MG/0.05 ML syringe 0.05ML
Ended Awarded Last action
- Contract number
- SPE2DR26FMDY8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,448
Award facts
- Contract value 100% obligated
- $30,447.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a firm fixed-price delivery order valued at $30.4K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of VABYSMO 6 MG/0.05 ML syringes. This delivery order was awarded on December 1, 2025, with an ultimate completion date of December 22, 2025, and carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors to supply pharmaceutical products supporting Department of Defense military healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, holding an Indefinite Delivery Contract designated SPE2DR with a ceiling value of $499.9M and completion date of December 31, 2036. The company's extensive product portfolio encompasses branded and generic prescription medications, biologics, specialty pharmaceuticals, and medical consumables, with demonstrated performance on numerous delivery orders across multiple therapeutic categories. This delivery order for VABYSMO, an ophthalmic pharmaceutical product, exemplifies the contractor's role in fulfilling the diverse and specialized pharmaceutical requirements of the Department of Defense's military medical system, with no identified subcontractor relationships in the award documentation.
Quick answers
Who was awarded contract SPE2DR26FMDY8?
SPE2DR26FMDY8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FMDY8 worth?
The government has obligated $30,448 on SPE2DR26FMDY8.
Is contract SPE2DR26FMDY8 an order under another contract?
Yes. SPE2DR26FMDY8 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMDY8 competed?
The extent of competition for SPE2DR26FMDY8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award